| ★ | GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | |
| 10 | Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome | | 2.0K | Estados Unidos | 68 |
| 18 | Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D | | 1.6K | Estados Unidos | 67 |
| 3 | Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes | | 475 | Estados Unidos | 74 |
| 15 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 67 |
| 20 | Dietary Interventions to Slow Metabolic Deterioration in Menopausal Patients | | 175 | Estados Unidos | 66 |
| 1 | GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | 80 |
| 2 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 74 |
| 16 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 67 |
| 5 | Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD | | 91 | Estados Unidos | 73 |
| 11 | How a Nephrologist Diagnoses and Manages Chronic Kidney Disease | | 70 | Estados Unidos | 68 |
| 7 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 71 |
| 19 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 66 |
| 4 | GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 73 |
| 9 | SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026 | | 48 | Estados Unidos | 69 |
| 13 | Screening for Type 1 Diabetes in Adults: What Needs to Change | | 42 | Estados Unidos | 67 |
| 12 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 67 |
| 17 | B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD | | 27 | Estados Unidos | 67 |
| 6 | Does Insulin Resistance Harm the Lungs? CT Data Offers New Clues | ATS 2026 | | 25 | Estados Unidos | 72 |
| 14 | What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD | | 12 | Estados Unidos | 67 |
| 8 | Key Diagnostic and Therapeutic Pearls for Connective Tissue Disease, With Michelle Min, MD | | 8 | Estados Unidos | 69 |